Literature DB >> 17955169

Uncontrolled headache induced by oxcarbazepine.

Elcio Juliato Piovesan1, Helio Ghizoni Teive, Luciano de Paola, Carlos Eduardo Silvado, Ana Crippa, Vanise Campos Gomes Amaral, Marcos Vinicius Della Colleta, Fabrizio Di Stani, Lineu Cesar Werneck.   

Abstract

Headache induced by acute exposure to a specific drug constitutes an idiosyncratic side effect. Metabolic imbalance appears as the leading aetiology, among several other hypotheses. Either primary headaches show a higher susceptibility to this idiosyncratic reaction or a drug-induced primary headache evolves in intensity and duration, becoming uncontrolled until the complete discontinuation of the drug in consideration. The goal of this study is to describe three patients diagnosed with migraine and epilepsy (both under control) who evolved into status migrainosus after the introduction of oxcarbazepine (OXC), as part of a switch off from carbamazepine (CBZ). Twenty-four to seventy-two hours following the switch, all patients developed intractable headache, despite the use of different symptomatic drugs. Complete recovery of the headache symptoms occurred only after OXC was discontinued. We discuss the potential mechanisms associated to OXC and status migrainosus, drug-induced headaches and uncontrolled headaches.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17955169      PMCID: PMC3476151          DOI: 10.1007/s10194-007-0415-6

Source DB:  PubMed          Journal:  J Headache Pain        ISSN: 1129-2369            Impact factor:   7.277


  9 in total

1.  The International Classification of Headache Disorders: 2nd edition.

Authors: 
Journal:  Cephalalgia       Date:  2004       Impact factor: 6.292

2.  Oxcarbazepine-induced headache.

Authors:  A Palmieri
Journal:  Cephalalgia       Date:  2007-01       Impact factor: 6.292

3.  Towards a definition of intractable headache for use in clinical practice and trials.

Authors:  P J Goadsby; J Schoenen; M D Ferrari; S D Silberstein; D Dodick
Journal:  Cephalalgia       Date:  2006-09       Impact factor: 6.292

Review 4.  Oxcarbazepine in the treatment of epilepsy.

Authors:  T A Glauser
Journal:  Pharmacotherapy       Date:  2001-08       Impact factor: 4.705

5.  Drug-related headache.

Authors:  H Askmark; P O Lundberg; S Olsson
Journal:  Headache       Date:  1989-07       Impact factor: 5.887

6.  Status migrainosus: causative and therapeutic aspects.

Authors:  J R Couch; S Diamond
Journal:  Headache       Date:  1983-05       Impact factor: 5.887

7.  Hyponatremia from oxcarbazepine and carbamazepine.

Authors:  Xiaoming Dong; Ilo E Leppik; James White; John Rarick
Journal:  Neurology       Date:  2005-12-27       Impact factor: 9.910

8.  Effects of oxcarbazepine on sodium concentration and water handling.

Authors:  Rajesh C Sachdeo; Alan Wasserstein; Peter J Mesenbrink; Joseph D'Souza
Journal:  Ann Neurol       Date:  2002-05       Impact factor: 10.422

Review 9.  Management of hyponatremia.

Authors:  Kian Peng Goh
Journal:  Am Fam Physician       Date:  2004-05-15       Impact factor: 3.292

  9 in total
  1 in total

1.  Lesson of the month 1: To stop a fit, but swinging low.

Authors:  Osakpolor Ogbebor; Ankit Agrawal; Balaji Yegneswaran
Journal:  Clin Med (Lond)       Date:  2018-06       Impact factor: 2.659

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.